Highlights
NASDAQ: REGN       Regeneron Pharmaceuticals
Last Price Today's Change   Day's Range   Trading Volume
666.115   +11.105 (1.70%)  652.03 - 670.96  240,954

Overview

 
Avg Volume (4 weeks):632,693
4 Weeks Range:597.76 - 725.805
4 Weeks Price Volatility (%):
53.38%
52 Weeks Range:492.13 - 725.805
52 Weeks Price Volatility (%):
74.46%
Average Price Target: 430.00
Price Target Upside/Downside: -236.115

Headlines



No recent Headlines for this stock.


Business Background

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. As of December 31, 2016, the Company had 16 product candidates in clinical development, which consisted of a Trap-based clinical program and 15 fully human monoclonal antibody product candidates.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

5785  3640  1201  1664 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 IMPP 0.48-0.285 
 TQQQ 32.69+2.04 
 ISBC 13.87-0.35 
 SNDL 0.44-0.025 
 SQQQ 50.34-3.71 
 AMD 102.31+8.07 
 MKD 0.15+0.034 
 NLY 6.45-0.24 
 AUVI 1.30+0.26 
 NIO 16.369+1.819